Cognitive dysfunction in schizophrenia: comparison of treatment with a novel atypical antipsychotic agent versus conventional neuroleptic drugs

Author： Gallhofer B.  

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.5, Iss.3, 1995-09, pp. : 200-201

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neuroleptic Malignant Syndrome Associated with Atypical Antipsychotic Drugs

By Trollor Julian N.   Chen Xiaohua   Sachdev Perminder S.  

CNS Drugs, Vol. 23, Iss. 6, 2009-05 ,pp. : 477-492

Adis International

Access to resources Recommend Favorite

Mechanism of Action of Atypical Antipsychotic Drugs and the Neurobiology of Schizophrenia

By Horacek Jiri   Bubenikova-Valesova Vera   Kopecek Milan   Palenicek Tomas   Dockery Colleen   Mohr Pavel   Höschl Cyril  

CNS Drugs, Vol. 20, Iss. 5, 2006-01 ,pp. : 389-409

Adis International

Access to resources Recommend Favorite

Pharmacogenetics of Antipsychotic Drugs in Schizophrenia Treatment

By Tybura Piotr   Trzesniowska-Drukala Beata   Samochowiec Jerzy  

Current Psychopharmacology, Vol. 1, Iss. 1, 2012-02 ,pp. : 47-60

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetics of Antipsychotic Drugs in Schizophrenia Treatment

By  

Current Psychopharmacology, Vol. 1, Iss. 1, 2012-02 ,pp. : 47-60

Bentham Science Publishers

Access to resources Recommend Favorite

Recent advances in novel atypical antipsychotic agents: potential therapeutic agents for the treatment of schizophrenia

By Nakazato A.   Okuyama S.  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 1, 2000-01 ,pp. : 75-98

Informa Healthcare

Access to resources Recommend Favorite